Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways-Reference-Cited by-同舟云学术

Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways

Published:2020-12 Issue:12 Volume:140 Page:2455-2465.e10
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Adam Christian^ORCID,Fusi Lorenza^ORCID,Weiss Neele^ORCID,Goller Simon G.^ORCID,Meder Katharina^ORCID,Frings Verena G.^ORCID,Kneitz Hermann^ORCID,Goebeler Matthias^ORCID,Houben Roland^ORCID,Schrama David^ORCID,Schmidt Marc^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference47 articles.

1. Resistance to MAPK inhibitors in melanoma involves activation of the IGF1R-MEK5-Erk5 pathway;Benito-Jardón;Cancer Res,2019

2. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition;Cagnol;Oncogene,2013

3. Multifunctional role of Erk5 in multiple myeloma;Carvajal-Vergara;Blood,2005

4. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation;de Jong;Nat Commun,2016

5. Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial;Dummer;Lancet Oncol,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib;FEBS Letters;2024-07-08

2. Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage;Scientific Reports;2024-05-22

3. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04

4. BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS‐mutant melanoma cells: Insights into mode of action and resistance mechanisms;International Journal of Cancer;2023-12-11

5. Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5;Journal of Medicinal Chemistry;2023-09-26